Interaction of lithium and angiotensin-converting enzyme inhibitors
Pulik, M.; Lida, H.
Presse Medicale 17(15): 755
1988
ISSN/ISBN: 0755-4982 PMID: 2968560 Document Number: 306741
Document emailed within 1 workday
Related Documents
Ionescu, S.D.; Sandru, V.; Leuciuc, E.; Manea, P.; Burdujan, A.; Tovarniţchi, S.; Cosovanu, A. 2002: Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 106(1): 128-131Prabhakar, Y.S.; Gupta, S.P. 1985: Structure-Activity relationship study on angiotensin-converting enzyme inhibitors--investigation of hydrophobic interaction in inhibition mechanism Indian Journal of Biochemistry and Biophysics 22(5): 318-320
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759
Jover, B.; Mimran, A. 1994: Angiotensin II receptor antagonists versus angiotensin converting enzyme inhibitors: effects on renal function Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 12(9): S3-S9
Krzesinski, J.M.; Montrieux, C.; Scheen, A.J. 2006: Angiotensin converting enzyme inhibitors or angiotensin Ii receptor blocker in cardiovascular and renal pathology in 2006: what does EBM teach us? Revue Medicale de Liege 61(5-6): 414-422
Surabenjawong, U.; Thunpiphat, N.; Chatsiricharoenkul, S.; Monsomboon, A. 2013: Prevalence of hyperkalemia in adult patients taking spironolactone and angiotensin converting enzyme inhibitors or angiotensin receptor blockers Journal of the Medical Association of Thailand 96(8): 905-910
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin converting enzyme inhibitors and angiotensin Ii receptor blockers on angiogenesis of gastric cancer in a nude mouse model Zhonghua Wei Chang Wai Ke Za Zhi 11(6): 565-568
Mahieu, M.; Houvenagel, E.; Leduc, J.J.; Choteau, P. 1988: Lithium-converting enzyme inhibitors: a combination to avoid? Presse Medicale 17(6): 281
Wang, L.; Cai, S.-r.; Zhang, C.-h.; He, Y.-l.; Zhan, W.-h.; Wu, H.; Peng, J.-j. 2008: Effects of angiotensin-converting enzyme inhibitors and angiotensin Ii type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model Chinese Medical Journal 121(21): 2167-2171
Jasik, M.; Zdrojewicz, Z.; Stawicki, S. 1999: The activity of renin-angiotensin-aldosterone system (RAA) and possibilities of application angiotensin converting enzyme inhibitors (ACE I) in selected diseases of endocrine glands Wiadomosci Lekarskie 52(3-4): 202-210
Squire, I.B.; MacFayden, R.J.; Reid, J.L.; Devlin, A.; Lees, K.R. 1996: Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure Journal of Cardiovascular Pharmacology 27(5): 657-666
Humke, U.; Levens, N.; Wood, J.; Hofbauer, K. 1992: The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system Journal of Pharmacology and Experimental Therapeutics 260(1): 29-35
Inzhutova, A.I.; Salmina, A.B.; Petrova, M.M. 2007: Pronounced homeostatic action of angiotensin converting enzyme inhibitors with high affinity to tissue renin-angiotensin-aldosterone system on cellular membranes Kardiologiia 47(8): 49-52
Dipalma, J.R. 1980: Angiotensin-converting enzyme inhibitors American Family Physician 22(5): 164-165
Rizzoni, D. 1991: Angiotensin-converting enzyme inhibitors Recenti Progressi in Medicina 82(4): 251-252
Abe, K. 1985: Angiotensin converting enzyme inhibitors Nihon Rinsho. Japanese Journal of Clinical Medicine 43(5): 949-955
Renke, M.; Rutkowski, Pław.; Tylicki, L.; Zietkiewicz, M.; Larczyński, W.; Rutkowski, Bław. 2008: Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline Przeglad Lekarski 65(6): 312-314
Vijan, S.G. 2009: Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients Journal of the Indian Medical Association 107(3): 178-182
Larsen, J.K.; Nielsen, M.B.; Jespersen, T.W. 1996: Angiotensin-converting enzyme inhibitors and anesthesia Ugeskrift for Laeger 158(43): 6081-6084